HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand April 15, 2021
Sanofi Unveils First Global Research Institute in China to Develop Innovative Drugs April 14, 2021Life Science
HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper March 25, 2021Life Science
HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety March 23, 2021Life Science
What Does HempFusion Entry onto China’s Ecommerce Giant, Tmall, Mean for Investors? March 18, 2021Life Science
HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s T-Mall Global, Reaching More Than 750 Million Potential New Consumers March 18, 2021Life Science
HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer March 9, 2021Life Science
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency March 3, 2021Life Science
NAI500 Special Coverage: With Global CBD Legislations Solidifying, is the Industry at a Tipping Point for Investors? March 2, 2021Cannabis, Life Science
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility February 26, 2021Cannabis, Life Science
Healthcare Roundup – FDA says COVID-19 vaccines targeting variants won’t need lengthy trials; Recreational marijuana use officially legalized in New Jersey February 23, 2021Life Science
Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify February 17, 2021Cannabis, Life Science
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York February 17, 2021Cannabis, Life Science
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva February 16, 2021Life Science
